Dali Pharmaceuticalco.,Ltd 603963.SS Stock
Dali Pharmaceuticalco.,Ltd Price Chart
Dali Pharmaceuticalco.,Ltd 603963.SS Financial and Trading Overview
| Dali Pharmaceuticalco.,Ltd stock price | 8.26 CNY |
| Previous Close | 10.34 CNY |
| Open | 10.34 CNY |
| Bid | 10.41 CNY x 0 |
| Ask | 10.42 CNY x 0 |
| Day's Range | 10.33 - 10.46 CNY |
| 52 Week Range | 10.2 - 20.22 CNY |
| Volume | 1.31M CNY |
| Avg. Volume | 2.12M CNY |
| Market Cap | 2.29B CNY |
| Beta (5Y Monthly) | 0.220547 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | June 23, 2021 |
| 1y Target Est | N/A |
603963.SS Valuation Measures
| Enterprise Value | 2.05B CNY |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 17.672478 |
| Price/Book (mrq) | 5.738699 |
| Enterprise Value/Revenue | 15.843 |
| Enterprise Value/EBITDA | -340.594 |
Trading Information
Dali Pharmaceuticalco.,Ltd Stock Price History
| Beta (5Y Monthly) | 0.220547 |
| 52-Week Change | -31.47% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 20.22 CNY |
| 52 Week Low | 10.2 CNY |
| 50-Day Moving Average | 11.15 CNY |
| 200-Day Moving Average | 13.19 CNY |
603963.SS Share Statistics
| Avg. Volume (3 month) | 2.12M CNY |
| Avg. Daily Volume (10-Days) | 1.36M CNY |
| Shares Outstanding | 219.7M |
| Float | 61.48M |
| Short Ratio | N/A |
| % Held by Insiders | 73.92% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1.3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -13.17% |
| Operating Margin (ttm) | -16.64% |
| Gross Margin | 52.84% |
| EBITDA Margin | -4.65% |
Management Effectiveness
| Return on Assets (ttm) | -2.63% |
| Return on Equity (ttm) | -4.18% |
Income Statement
| Revenue (ttm) | 129.41M CNY |
| Revenue Per Share (ttm) | 0.59 CNY |
| Quarterly Revenue Growth (yoy) | -7.39% |
| Gross Profit (ttm) | N/A |
| EBITDA | -6019752 CNY |
| Net Income Avi to Common (ttm) | -17045684 CNY |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 264.12M CNY |
| Total Cash Per Share (mrq) | 1.2 CNY |
| Total Debt (mrq) | 42.72M CNY |
| Total Debt/Equity (mrq) | 10.72 CNY |
| Current Ratio (mrq) | 4.44 |
| Book Value Per Share (mrq) | 1.814 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2761477 CNY |
| Levered Free Cash Flow (ttm) | -30924392 CNY |
Profile of Dali Pharmaceuticalco.,Ltd
| Country | China |
| State | N/A |
| City | Dali |
| Address | No. 118, West Huancheng Road |
| ZIP | 671000 |
| Phone | 86 87 1683 58699 |
| Website | https://www.daliyaoye.cn |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 289 |
Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection products of 20 varieties with 44 specifications of the injection drug approval number. The company's products include xingnaojing, shenmai, and astragalus injections, as well as leucocin A and citicoline injections. It also has 31 patents, including 11 invention patents, 16 utility models, and 3 design patents. The company was founded in 1996 and is headquartered in Dali, China.
Q&A For Dali Pharmaceuticalco.,Ltd Stock
What is a current 603963.SS stock price?
Dali Pharmaceuticalco.,Ltd 603963.SS stock price today per share is 8.26 CNY.
How to purchase Dali Pharmaceuticalco.,Ltd stock?
You can buy 603963.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dali Pharmaceuticalco.,Ltd?
The stock symbol or ticker of Dali Pharmaceuticalco.,Ltd is 603963.SS.
Which industry does the Dali Pharmaceuticalco.,Ltd company belong to?
The Dali Pharmaceuticalco.,Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Dali Pharmaceuticalco.,Ltd have in circulation?
The max supply of Dali Pharmaceuticalco.,Ltd shares is 219.7M.
What is Dali Pharmaceuticalco.,Ltd Price to Earnings Ratio (PE Ratio)?
Dali Pharmaceuticalco.,Ltd PE Ratio is now.
What was Dali Pharmaceuticalco.,Ltd earnings per share over the trailing 12 months (TTM)?
Dali Pharmaceuticalco.,Ltd EPS is -0.1 CNY over the trailing 12 months.
Which sector does the Dali Pharmaceuticalco.,Ltd company belong to?
The Dali Pharmaceuticalco.,Ltd sector is Healthcare.